Is Giant Cell Tumor of Bone Serious?
Whether giant cell tumors of bone are serious or not cannot be generalized and needs to be analyzed based on specific circumstances.
Giant cell tumor of bone is a locally aggressive tumor composed of proliferating mononuclear stromal cells and evenly distributed osteoclasts. Its severity is closely related to the pathological grade of the tumor. If pathological examination, imaging examination, etc. indicate that the tumor grade is 1, it is relatively benign. After standardized treatment, the prognosis is good and the situation is not serious at this time. However, if the tumor grade reaches Grade 2 or above, the disease is more severe and falls into the category of malignant tumors, which can easily affect the patient's quality of life and survival time.

Symptoms of giant cell tumors of bone include pain, swelling, joint dysfunction, etc. These symptoms can cause certain pain and inconvenience to patients. Especially when the tumor invades the joint surface, it may cause limited joint movement or even loss of movement ability, seriously affecting the patient's daily life and work. In addition, malignant giant cell tumors of bone may cause night pain and disturb patients during sleep.
The treatment of giant cell tumors of bone is mainly surgical, such as local excision, curettage and bone grafting. Before and after surgery, adjuvant treatments such as radiotherapy and chemotherapy can be used according to the patient's condition. For patients who are detected early and treated promptly, a better prognosis can often be obtained through standardized treatment plans. However, if treatment is delayed or the tumor has developed into malignant disease, the prognosis may be poor and more radical treatment measures such as amputation may be required to control the disease.
(Common therapeutic drugs for bone giant cell cancer include: pembrolizumab, cetuximab, nivolumab, etc. For specific drug details, please see the homepage of the website or click for consultation)
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)